Гематология / лейкозы / лимфомы

Epcoritamab Combo Receives Canadian Approval in R/R Follicular Lymphoma

Linvoseltamab Shows Deep Responses in High-Risk Smoldering Multiple Myeloma

Optimizing Cilta-Cel Sequencing and Community Coordination in Multiple Myeloma

NCI awards $3.46 million grant to study resistance to acute myeloid leukemia treatment - News-Medical

NCI awards $3.46 million grant to study resistance to acute myeloid leukemia treatment News-Medical

Advocacy and Support in Relapsed/Refractory Multiple Myeloma

Balancing Quality of Life and Treatment Goals in Relapsed/Refractory Multiple Myeloma

Daily vitamin C linked to fewer adverse events in pre-leukemia trial

Daily vitamin C linked to fewer adverse events in pre-leukemia trial Nutrition Insight

Blinatumomab improves event-free survival in children with high-risk B-cell ALL

Blinatumomab is associated with significantly higher event-free survival among children with newly diagnosed high-risk B-cell acute lymphoblastic leukemia (ALL), according to a study published in the Sept. 17 issue of the New England Journal of Medicine.

A Family with Deep CU Ties Supports a Home-Grown Study Seeking a Better Leukemia Treatment

A Family with Deep CU Ties Supports a Home-Grown Study Seeking a Better Leukemia Treatment University of Colorado Anschutz

Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas

Lantern Pharma Secures USPTO Notice of Allowance for LP‑284 Treatment Patent in Aggressive B‑Cell Lymphomas Business Wire

Navigating Autologous vs Allogeneic Transplant Selection in T-Cell Lymphoma

Витамин С может улучшить выживаемость при высоком риске развития лейкоза

Витамин С может улучшить выживаемость при высоком риске развития лейкоза Medvestnik

CELMoDs After T-Cell–Engaging Therapy in Multiple Myeloma

Iberdomide-Based Treatment in Lenalidomide-Refractory Multiple Myeloma

Screening for CHIP Mutations to Guide CAR T Cell Candidacy in Lymphoma